BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11416742)

  • 1. F-18 FDG uptake in a bone infarct: a case report.
    Grigolon MV; Delbeke D
    Clin Nucl Med; 2001 Jul; 26(7):613-4. PubMed ID: 11416742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ¹⁸F-FDG PET/CT in differentiation of a benign lesion and metastasis on the ribs of cancer patients.
    Choi HS; Yoo IeR; Park HL; Choi EK; Kim SH; Lee WH
    Clin Imaging; 2014; 38(2):109-14. PubMed ID: 24361174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.
    Homann G; Mustafa DF; Ditt H; Spengler W; Kopp HG; Nikolaou K; Horger M
    Acad Radiol; 2015 Apr; 22(4):505-12. PubMed ID: 25586709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
    Nakamoto Y; Osman M; Wahl RL
    Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic abscess of rib on
    Yang F; Cao L; Chen F; Huang X; Li S
    Hell J Nucl Med; 2022; 25(3):315-316. PubMed ID: 36507887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked Hematopoiesis Masquerading Multiple Bone Metastasis in a Lung Cancer Patient With Myelodysplastic Syndrome.
    Imataki O; Uchida S; Shiroshita K; Kida J; Uemura M
    Clin Nucl Med; 2015 Jul; 40(7):574-5. PubMed ID: 26018680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG PET/CT Image of a Solitary Rib Hamartoma.
    Xiao L; Yang L; Li L
    Clin Nucl Med; 2022 Mar; 47(3):e257-e258. PubMed ID: 34661555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
    Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
    Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
    Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F-18 FDG positron emission tomography and benign fractures.
    Shon IH; Fogelman I
    Clin Nucl Med; 2003 Mar; 28(3):171-5. PubMed ID: 12592121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT Helps Downgrade an Aggressive-Appearing Rib Mass to a Probable Benign Lesion in a 9-Year-Old Girl.
    Ghaderi KF; Yoo DC; Hart J
    Clin Nucl Med; 2016 Mar; 41(3):221-3. PubMed ID: 26562571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer.
    Yang SN; Liang JA; Lin FJ; Kao CH; Lin CC; Lee CC
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):325-8. PubMed ID: 12073051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection by (18)F-FDG PET of unsuspected extensive bone marrow metastases in a case of basosquamous carcinoma of the cheek.
    Joshi P; Kulkarni MJ; Abhyankar A; Shet T; Basu S
    Hell J Nucl Med; 2011; 14(3):307-8. PubMed ID: 22087455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
    Al-Muqbel KM; Yaghan RJ; Al-Omari MH; Rousan LA; Dagher NM; Al Bashir S
    Nucl Med Commun; 2016 Jun; 37(6):593-601. PubMed ID: 26813990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
    Du Y; Cullum I; Illidge TM; Ell PJ
    J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation in imaging techniques for the early detection of bone metastases in a case of breast cancer].
    Răileanu I; Rusu V; Talbot JN; Aide N; Hugentobler A; Montravers F; Grahek D; Kerrou K
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):210-3. PubMed ID: 15688788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Positron emission tomography and bone scintigraphy of an osteoclast metastasis].
    Chapot C; al Roubaie Z; Kirsch CM
    Nuklearmedizin; 1998 Aug; 37(5):183-6. PubMed ID: 9728346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.